These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27392978)

  • 21. Incidence and risk factors of carbapenem-resistant
    Aleidan FAS; Alkhelaifi H; Alsenaid A; Alromaizan H; Alsalham F; Almutairi A; Alsulaiman K; Abdel Gadir AG
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):393-398. PubMed ID: 32930620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control.
    Abboud CS; de Souza EE; Zandonadi EC; Borges LS; Miglioli L; Monaco FC; Barbosa VL; Cortez D; Bianco AC; Braz A; Monteiro J
    J Hosp Infect; 2016 Sep; 94(1):60-4. PubMed ID: 27451040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    Bar-Yoseph H; Hussein K; Braun E; Paul M
    J Antimicrob Chemother; 2016 Oct; 71(10):2729-39. PubMed ID: 27317444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.
    Bogan C; Kaye KS; Chopra T; Hayakawa K; Pogue JM; Lephart PR; Bheemreddy S; Lazarovitch T; Zaidenstein R; Perez F; Bonomo RA; Marchaim D
    Am J Infect Control; 2014 Jun; 42(6):612-20. PubMed ID: 24837111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.
    Schechner V; Kotlovsky T; Tarabeia J; Kazma M; Schwartz D; Navon-Venezia S; Carmeli Y
    Infect Control Hosp Epidemiol; 2011 May; 32(5):497-503. PubMed ID: 21515981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
    Correa AAF; Fortaleza CMCB
    Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
    Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
    Marchaim D; Chopra T; Perez F; Hayakawa K; Lephart PR; Bheemreddy S; Blunden C; Hujer AM; Rudin S; Shango M; Campbell M; Varkey J; Slim J; Ahmad F; Patel D; Chen TY; Pogue JM; Salimnia H; Dhar S; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):861-71. PubMed ID: 21828966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
    Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
    Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes.
    Kim S; Russell D; Mohamadnejad M; Makker J; Sedarat A; Watson RR; Yang S; Hemarajata P; Humphries R; Rubin Z; Muthusamy VR
    Gastrointest Endosc; 2016 Jun; 83(6):1121-9. PubMed ID: 26993149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for mortality among carbapenem-resistant enterobacteriaceae carriers with focus on immunosuppression.
    Bar-Yoseph H; Cohen N; Korytny A; Andrawus ER; Even Dar R; Geffen Y; Hussein K; Paul M
    J Infect; 2019 Feb; 78(2):101-105. PubMed ID: 30312647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
    Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
    Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.